COP
54
-2
HOG
33
4
NWS
69
7
TEL
66
6
IVZ
48
2
AEE
64
4
MCD
50
-2
ABBV
39
8
KR
38
4
AIV
70
2
HBI
55
-4
ISRG
76
2
EFX
36
4
SWKS
49
11
ROP
59
5
CVS
50
2
CI
52
7
AIG
44
6
SWK
61
5
GLW
46
4
COP
54
-2
HOG
33
4
NWS
69
7
TEL
66
6
IVZ
48
2
AEE
64
4
MCD
50
-2
ABBV
39
8
KR
38
4
AIV
70
2
HBI
55
-4
ISRG
76
2
EFX
36
4
SWKS
49
11
ROP
59
5
CVS
50
2
CI
52
7
AIG
44
6
SWK
61
5
GLW
46
4
Financhill
Back

Precision BioSciences Vs. Protagonist Therapeutics Industry Stock Comparison

Sell
4

DTIL
Precision BioSciences

Last Price:
7.21
Seasonality Move:
-6.51%
Sell
33

PTGX
Protagonist Therapeutics

Last Price:
46.45
Seasonality Move:
11.46%
Sell
4
Precision BioSciences (DTIL) is a Sell

Is Precision BioSciences a Buy, Sell or Hold?

  • The current Precision BioSciences [DTIL] share price is $6.50. The Score for DTIL is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • DTIL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
33
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $41.65. The Score for PTGX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DTIL Stock Price Chart

What is Precision BioSciences's stock price today?

  • The Precision BioSciences share price today is $6.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DTIL is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $41.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

DTIL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.49 Sell
Relative Strength Index (14 RSI): 19.42 Sell
Chaikin Money Flow: -161120 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 41.01 Sell
Chaikin Money Flow: -281616 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

DTIL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.49 Sell
20-day SMA: 8.04 Sell
50-day SMA: 8.77 Sell
200-day SMA: 10.64 Sell
8-day EMA: 7.36 Sell
20-day EMA: 7.92 Sell
50-day EMA: 8.57 Sell
200-day EMA: 10.91 Sell

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.17 Buy
20-day SMA: 44.7 Sell
50-day SMA: 45.23 Sell
200-day SMA: 35.68 Buy
8-day EMA: 41.66 Sell
20-day EMA: 43.5 Sell
50-day EMA: 43.92 Sell
200-day EMA: 36.78 Buy

Precision BioSciences Earnings Growth & DTIL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $20.23 per share, and a decrease next year of $9.65 per share.

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.

Precision BioSciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):